Detalhe da pesquisa
1.
Immune evasion by Cryptococcus gattii in vaccinated mice coinfected with C. neoformans.
Front Immunol
; 15: 1356651, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38469300
2.
Protection against experimental cryptococcosis elicited by Cationic Adjuvant Formulation 01-adjuvanted subunit vaccines.
bioRxiv
; 2024 Apr 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38712080
3.
Chitosan-Deficient Cryptococcus as Whole-Cell Vaccines.
Methods Mol Biol
; 2775: 393-410, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38758333
4.
Immunological correlates of protection following vaccination with glucan particles containing Cryptococcus neoformans chitin deacetylases.
NPJ Vaccines
; 8(1): 6, 2023 Feb 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36732332
5.
Cross-reactivity between vaccine antigens from the chitin deacetylase protein family improves survival in a mouse model of cryptococcosis.
Front Immunol
; 13: 1015586, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36248898
6.
Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles.
mBio
; 13(1): e0336721, 2021 02 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35089095
7.
Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens.
Vaccine
; 38(3): 620-626, 2020 01 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31699504
8.
Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species.
mBio
; 8(6)2017 11 28.
Artigo
Inglês
| MEDLINE | ID: mdl-29184017